Aubin-Pouliot Annick, Delagnes Elise A, Eisele David W, Chang Jolie L, Ryan William R
Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, U.S.A.
University of California-San Francisco, School of Medicine, San Francisco, California, U.S.A.
Laryngoscope. 2016 Jan;126(1):93-9. doi: 10.1002/lary.25521. Epub 2015 Aug 8.
OBJECTIVES/HYPOTHESIS: Introduce the Chronic Obstructive Sialadenitis Symptoms (COSS) questionnaire to quantify chronic sialadenitis symptoms and assess the impact of sialendoscopic-assisted salivary duct surgery (SASDS).
Retrospective outcome symptoms questionnaire study.
The COSS questionnaire assesses the severity of sialadenitis symptoms from 0 to 100. Patients who underwent SASDS from April 2006 to December 2013 completed the COSS questionnaire and the ShortForm8 Health Survey (SF-8) based on current symptoms, and reported whether they had complete, partial, or no symptomatic response to SASDS.
Sixty-six of the 156 (43%) contacted patients completed the questionnaires who had had symptoms in 26 submandibular ducts and 53 parotid ducts. The mean COSS score was higher for parotid ducts (12.0; interquartile range [IQR] 1.0-20.0) than for submandibular ducts (7.6; IQR 0.5-15.0) but not significantly so (P = 0.20). Thirty-eight (60%) patients reported complete resolution of symptoms, with a mean COSS score of 4.5 (IQR 0-7). Twenty-one (33%) patients reported partial resolution, with a mean COSS score of 18.5 (IQR 11.3-22.8). Five (8%) patients reported no improvement, with a mean COSS score of 25.1 (IQR 15.2-35). Thirty-six (46%) ducts with sialoliths had a significantly lower mean COSS score (5.8; IQR 0-9.5) compared to those without sialoliths (14.2; IQR 4.5-21.5, P = 0.0004). There was no significant difference in SF-8 survey scores between these groups.
The COSS questionnaire is a novel survey instrument to measure obstructive sialadenitis symptom severity that could be helpful in defining outcomes of SASDS. COSS scores under 10 correlate with complete resolution of symptoms, whereas scores between 10 and 25 correlate with partial resolution.
目的/假设:引入慢性阻塞性涎腺炎症状(COSS)问卷,以量化慢性涎腺炎症状,并评估涎腺内镜辅助涎腺导管手术(SASDS)的效果。
回顾性结果症状问卷研究。
COSS问卷评估涎腺炎症状的严重程度,范围为0至100。2006年4月至2013年12月接受SASDS的患者根据当前症状完成了COSS问卷和简短健康调查(SF-8),并报告了他们对SASDS的症状反应是完全缓解、部分缓解还是无改善。
156名联系患者中的66名(43%)完成了问卷,这些患者的26条下颌下腺导管和53条腮腺导管有症状。腮腺导管的平均COSS评分(12.0;四分位间距[IQR]1.0 - 20.0)高于下颌下腺导管(7.6;IQR 0.5 - 15.0),但差异无统计学意义(P = 0.20)。38名(60%)患者报告症状完全缓解,平均COSS评分为4.5(IQR 0 - 7)。21名(33%)患者报告部分缓解,平均COSS评分为18.5(IQR 11.3 - 22.8)。5名(8%)患者报告无改善,平均COSS评分为25.1(IQR 15.2 - 35)。与无涎石的导管相比,36条(46%)有涎石的导管平均COSS评分显著更低(5.8;IQR 0 - 9.5)(14.2;IQR 4.5 - 21.5,P = 0.0004)。这些组之间的SF-8调查评分无显著差异。
COSS问卷是一种用于测量阻塞性涎腺炎症状严重程度的新型调查工具,有助于确定SASDS的治疗效果。COSS评分低于10与症状完全缓解相关,而评分在10至25之间与部分缓解相关。